Cannabics Pharmaceuticals Inc buy melinda
Start price
21.02.17
/
50%
€5.33
Target price
21.02.17
€6.00
Performance (%)
14.11%
End price
21.02.17
€6.08
Summary
This prediction ended on 21.02.17 with a price of €6.08. The BUY prediction by melinda finished with a performance of 14.11%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cannabics Pharmaceuticals Inc | - | - | - | - |
| iShares Core DAX® | -3.141% | 1.269% | 16.367% | 60.124% |
| iShares Nasdaq 100 | -3.518% | -1.355% | 2.670% | 101.416% |
| iShares Nikkei 225® | -3.396% | 3.283% | 17.041% | 47.915% |
| iShares S&P 500 | -2.943% | -0.533% | 1.373% | 64.215% |
Comments by melinda for this prediction
In the thread Cannabics Pharmaceuticals Inc diskutieren
ein anderer Cannabis
Itamar Borochov CEO Cannabics Pharmaceuticals, sagte : "Wir sind das erste Unternehmen weltweit eine Anti-Tumor - Diagnose Cannabinoide Patienten personalisierte Krebs zu bieten. Wir freuen uns , Pioniere auf dem Link Cannabis und personalisierte Krebstherapien zu sein. "
Stopped prediction by melinda for Cannabics Pharmaceuticals Inc
Cannabics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€2.10
02.01.18
02.01.18
€4.00
03.07.18
03.07.18
-63.24%
03.07.18
03.07.18
Cannabics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€0.84
24.08.17
24.08.17
€2.00
02.01.18
02.01.18
151.31%
02.01.18
02.01.18
Cannabics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€4.25
22.02.17
22.02.17
€7.00
22.08.17
22.08.17
-80.02%
22.08.17
22.08.17
Cannabics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€5.99
21.02.17
21.02.17
€7.00
22.02.17
22.02.17
16.86%
22.02.17
22.02.17
Cannabics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€3.80
17.02.17
17.02.17
€4.00
17.02.17
17.02.17
5.26%
17.02.17
17.02.17